PRPH
Price:
$2.19
Market Cap:
$41.78M
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab metho...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1994-04-04
Stock Exchange
NASDAQ
Ticker
PRPH
According to ProPhase Labs, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 66.23M. This represents a change of -39.84% compared to the average of 110.09M of the last 4 quarters.
The mean historical Enterprise Value of ProPhase Labs, Inc. over the last ten years is 64.43M. The current 66.23M Enterprise Value has changed 10.18% with respect to the historical average. Over the past ten years (40 quarters), PRPH's Enterprise Value was at its highest in in the June 2022 quarter at 226.73M. The Enterprise Value was at its lowest in in the March 2017 quarter at -4023860.00.
Average
64.43M
Median
34.39M
Minimum
21.51M
Maximum
150.44M
Discovering the peaks and valleys of ProPhase Labs, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 411.69%
Maximum Annual Enterprise Value = 150.44M
Minimum Annual Increase = -35.52%
Minimum Annual Enterprise Value = 21.51M
Year | Enterprise Value | Change |
---|---|---|
2023 | 97.01M | -35.52% |
2022 | 150.44M | 30.50% |
2021 | 115.28M | 0.81% |
2020 | 114.35M | 411.69% |
2019 | 22.35M | -34.93% |
2018 | 34.34M | 12.22% |
2017 | 30.60M | -11.12% |
2016 | 34.43M | 43.69% |
2015 | 23.96M | 11.41% |
2014 | 21.51M | -10.61% |
The current Enterprise Value of ProPhase Labs, Inc. (PRPH) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
120.91M
5-year avg
99.88M
10-year avg
64.43M
ProPhase Labs, Inc.’s Enterprise Value is less than LumiraDx Limited (377.41M), greater than Star Equity Holdings, Inc. (23.84M), greater than Enzo Biochem, Inc. (6.93M), greater than Genetron Holdings Limited (-48977790.00), greater than Neuronetics, Inc. (53.02M), greater than Intelligent Bio Solutions Inc. (559.53K), less than Biodesix, Inc. (232.35M), greater than Precipio, Inc. (9.01M), greater than DarioHealth Corp. (35.65M), less than Olink Holding AB (publ) (3.16B), greater than Exagen Inc. (42.34M), less than Sotera Health Company (6.57B), greater than Burning Rock Biotech Limited (-220822648.42), greater than Psychemedics Corporation (14.11M), less than Sera Prognostics, Inc. (254.28M),
Company | Enterprise Value | Market cap |
---|---|---|
377.41M | $0 | |
23.84M | $12.21M | |
6.93M | $59.04M | |
-48977790.00 | $127.29M | |
53.02M | $33.04M | |
559.53K | $5.99M | |
232.35M | $201.80M | |
9.01M | $9.12M | |
35.65M | $28.82M | |
3.16B | $3.24B | |
42.34M | $42.94M | |
6.57B | $4.47B | |
-220822648.42 | $28.68M | |
14.11M | $13.68M | |
254.28M | $257.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProPhase Labs, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ProPhase Labs, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is ProPhase Labs, Inc.'s Enterprise Value?
What is the highest Enterprise Value for ProPhase Labs, Inc. (PRPH)?
What is the 3-year average Enterprise Value for ProPhase Labs, Inc. (PRPH)?
What is the 5-year average Enterprise Value for ProPhase Labs, Inc. (PRPH)?
How does the current Enterprise Value for ProPhase Labs, Inc. (PRPH) compare to its historical average?